PLSE
What one share of Pulse Biosciences holds
Surgical and Medical Instruments and Apparatus
We are a novel ablation company committed to health innovation using our patented Nano-pulse Stimulation (“NPS”) technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to nonthermally clear or kill targeted cells.
Pulse Biosciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.02 |
|---|---|
| Profit | −$1.18 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.90 |
| Cash and investments | $1.44 |
| Book value | $1.41 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | — | −$0.37 | $0.01 | −$0.45 | — | $1.81 |
| 2016 | — | −$0.86 | $0.01 | −$0.74 | — | $1.90 |
| 2017 | — | −$1.73 | $0.17 | −$0.92 | — | $2.73 |
| 2018 | — | −$2.20 | $0.02 | −$1.42 | — | $3.22 |
| 2019 | — | −$2.26 | $0.03 | −$1.68 | — | $1.48 |
| 2020 | $0.00 | −$2.14 | $0.02 | −$1.54 | — | $0.90 |
| 2021 | $0.05 | −$2.28 | $0.02 | −$1.95 | — | $0.80 |
| 2022 | $0.02 | −$1.72 | $0.01 | −$1.40 | — | −$0.06 |
| 2023 | $0.00 | −$0.85 | $0.00 | −$0.67 | — | $0.80 |
| 2024 | $0.00 | −$0.92 | $0.00 | −$0.62 | — | $1.74 |
| 2025 | $0.01 | −$1.08 | $0.00 | −$0.81 | — | $1.19 |